EAM
MEDP icon

EULAV Asset Management’s Medpace MEDP Stock Holding History

EULAV Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Sell
32,509
-3
-0% -$1.39K 0.55% 56
2026
Q1 		$15.6M Sell
32,512
-6
-0% -$3.07K 0.5% 66
2025
Q4 		$18.3M Buy
32,518
+7
+0% +$3.97K 0.49% 65
2025
Q3 		$16.7M Buy
32,511
+10,406
+47% +$4.54M 0.39% 76
2025
Q2 		$6.94M Buy
22,105
+5
+0% +$1.5K 0.16% 118
2025
Q1 		$6.73M Hold
22,100
– – 0.17% 121
2024
Q4 		$7.34M Hold
22,100
– – 0.18% 120
2024
Q3 		$7.38M Hold
22,100
– – 0.18% 118
2024
Q2 		$9.1M Hold
22,100
– – 0.25% 101
2024
Q1 		$8.93M Hold
22,100
– – 0.25% 99
2023
Q4 		$6.77M Buy
22,100
+6,200
+39% +$1.67M 0.21% 108
2023
Q3 		$3.85M Hold
15,900
– – 0.14% 131
2023
Q2 		$3.82M Hold
15,900
– – 0.14% 135
2023
Q1 		$2.99M Hold
15,900
– – 0.12% 146
2022
Q4 		$3.38M Hold
15,900
– – 0.15% 129
2022
Q3 		$2.5M Hold
15,900
– – 0.11% 155
2022
Q2 		$2.38M Hold
15,900
– – 0.1% 166
2022
Q1 		$2.6M Hold
15,900
– – 0.08% 179
2021
Q4 		$3.46M Buy
15,900
+1,500
+10% +$314K 0.09% 175
2021
Q3 		$2.73M Buy
14,400
+500
+4% +$91.2K 0.07% 179
2021
Q2 		$2.46M Hold
13,900
– – 0.06% 183
2021
Q1 		$2.28M Hold
13,900
– – 0.06% 200
2020
Q4 		$1.94M Hold
13,900
– – 0.05% 208
2020
Q3 		$1.55M Hold
13,900
– – 0.05% 212
2020
Q2 		$1.29M Hold
13,900
– – 0.04% 220
2020
Q1 		$1.02M Hold
13,900
– – 0.04% 220
2019
Q4 		$1.17M Buy
13,900
+7,300
+111% +$565K 0.04% 242
2019
Q3 		$555K Buy
+6,600
New +$499K 0.02% 285

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

EULAV Asset Management's MEDP Position: Q2 2026 in Review

EULAV Asset Management reduced its Medpace (MEDP) stake by 0.01% in Q2 2026, selling an estimated $1.39K and leaving 32,509 shares worth $17.2M. The position accounts for 0.55% of the portfolio, ranked #56.

EULAV Asset Management first reported a position in MEDP in Q3 2019 and has held it in 28 quarters since. The position peaked at $18.3M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • EULAV Asset Management held 32,509 shares of Medpace worth $17.2M as of Q2 2026.
  • EULAV Asset Management sold 3 Medpace shares in Q2 2026, an estimated $1.39K.
  • Medpace made up 0.55% of EULAV Asset Management's portfolio in Q2 2026, its #56 holding.
  • EULAV Asset Management first reported a position in Medpace in Q3 2019 and has held it in 28 quarters since.
  • EULAV Asset Management's Medpace position peaked at $18.3M in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on EULAV Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.